McDermott Advises bd Capital Partners on the Acquisition Financing of Ascenti, a Technology-Led Disruptor in the UK Physiotherapy and Mental Wellbeing Markets - McDermott Will & Emery

McDermott Advises bd Capital Partners on the Acquisition Financing of Ascenti, a Technology-Led Disruptor in the UK Physiotherapy and Mental Wellbeing Markets

Overview


McDermott Will & Emery advised bd Capital Partners Limited, as sponsor, in connection with the acquisition financing of the Ascenti group which includes an asset backed lending component provided by M&G.

Ascenti is the leading independent provider of physiotherapy, mental health and selected clinical outsourcing services in the UK. They are a trusted partner to more than 20 NHS Clinical Commissioning Groups (CCGs) and hundreds of private businesses across the UK, serving NHS patients, pay as you go customers and private medical insurance members.

bd-Capital is a European firm dedicated to implement the next evolution of operationally-led investing: business leaders and private equity investors working in full partnership with company stakeholders. The firm targets control or co-control investments in European mid-market businesses with strong growth potential. The firm’s strategy is to invest in businesses where changing patterns in behaviour and technology disruption are creating growth opportunities.

McDermott’s team was led by finance partner Aymen Mahmoud and included partner Mark Fine, associate Giulia Venanzoni and trainee Ryan Clarke.

About McDermott


McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.